Chronic Inflammatory Skin Diseases: An Update for Clinician

Dear Colleagues,

Outstanding progresses have been done in the last few decades in dermatology, especially regarding chronic inflammatory skin diseases. Indeed, major advances in understanding the pathogenesis of the most common inflammatory skin diseases such as psoriasis, atopic dermatitis and hidradenitis suppurativa have led to the development of selective and targeted innovative therapies. The latter include biologic drugs (chimeric, humanized and fully human monoclonal antibodies), biosimilars and small molecules which have completely revolutionized chronic inflammatory skin diseases treatment.

However, significant research efforts are still needed. Precision medicine should guide genetic and pharmacogenomic studies in order to highlight biomarkers which could aid the clinician in predicting disease course, prompt diagnosing comorbidities, predicting treatment response and, therefore, performing an evidence-based treatment selection in order to have the highest possibility to guarantee the right treatment for the right patient at the right time.

The Special Issue entitled “"Chronic Inflammatory Skin Diseases: an Update for the Clinician” is now open for submissions, welcoming papers which aims to bring together the most relevant scientific research on chronic inflammatory skin diseases, focusing on epidemiology, burden, pathophysiology, and recent or emerging advancements in therapy.

Dr. Matteo Megna
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.